Patients with myeloid malignancies showed the same high seroconversion rate as the control cohort and a nonsignificant trend toward lower IgG antibody titers.
← all excerpts
Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia.
1
—
—